Infertility Diagnosis and Treatment Market
Global Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report by Diagnosis (Male Infertility Diagnosis and Female Infertility Diagnosis), and by Infertility Treatment (Male Infertility Treatment and Female Infertility Treatment) Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global infertility diagnosis and treatment market is anticipated to grow at a CAGR of 7.0% during the forecast period. Lifestyle factors such as smoking, stress, weight, and also the female age factor (age above 35 years) are the reason behind infertility. The major factor driving the growth of the global infertility diagnosis and treatment market during the forecast period is the increasing infertility rate across the globe. According to the Centers for Disease Control and Prevention (CDC), among heterosexual women aged 15 to 49 years with no prior births, about 1 in 5, or 19% are unable to get pregnant after one year of trying due to infertility. Additionally, about 1 in 4 or 26% of women in this group have difficulty getting pregnant or carrying a pregnancy to term due to impaired fecundity. Moreover, infertility and impaired fecundity are less common among women with one or more prior births. Furthermore, in this group, about 6% of married women aged 15 to 49 years are unable to get pregnant after one year of trying and 14% have difficulty getting pregnant or carrying a pregnancy to term. Hence, this is driving the demand for diagnosis and treatment of infertility which in turn is driving the growth of the market.
Impact of COVID-19 Pandemic on Global Infertility Diagnosis And Treatment Market
During COVID-19, many countries had been impacted by the pandemic, and the governments of these countries had ordered nationwide lockdowns which shut down operations of various industries. Additionally, the COVID-19 pandemic presented various challenges to clinical healthcare providers and patients such as managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions as well as protecting the public and hospital frontline workers from exposure to the COVID-19 infection across the globe. Furthermore, the market was also affected due to a significant drop in the number of patients undergoing infertility diagnosis and treatment during the COVID-19 pandemic.
Segmental Outlook
The global infertility diagnosis and treatment market is segmented based on diagnosis and treatment. Based on the diagnosis, the market is segmented into male infertility diagnosis (semen analysis, genetic testing, testicular biopsy, hormone testing, and others) and female infertility diagnosis (ovulation testing, hysterosalpingography, hysteroscopy, imaging testing, ovarian reserve testing, hormonal level testing, genetic testing, others testing). Based on the treatment, the market is segmented into male infertility treatment (drugs and medicine, surgical, assisted reproductive technology (ART), Others) and female infertility treatment (drugs and medicine, surgical, intrauterine insemination (IUI), assisted reproductive technology (ART), in vitro fertilization, intracytoplasmic sperm injection (ICSI), assisted hatching, others).
Global Infertility Diagnosis And Treatment Market Share by Infertility Treatment, 2021 (%)
Assisted Reproductive Technology (ART) to Hold a Prominent Share in the Global Infertility Diagnosis And Treatment Market.
Based on infertility treatment, the assisted reproductive technology (ART) segment is expected to grow at a significant rate during the forecast period. This is attributed to the growing awareness of the presence of ART as well as the rise in the success rate of this procedure and the growing acceptance of ART globally is likely to boost the growth of the segment.
Regional Outlook
The global infertility diagnosis and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Germany, Italy, Spain, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Asia-Pacific is anticipated to grow during the forecast period due to the increasing medical tourism in major countries such as China and India in the region.
Global Infertility Diagnosis And Treatment Market Growth by Region, 2022-2028
North America Region Holds a Prominent Share in the Global Infertility Diagnosis And Treatment Market
The North American region holds a prominent share in the infertility diagnosis and treatment market. The major factor driving the growth of the market in the region is due to the changing lifestyle, increasing the geriatric population, and rising awareness regarding infertility diagnosis and treatment are some of the few factors that push this region upward.
Market Players Outlook
The major companies serving the global infertility diagnosis and treatment market include Bayer AG, Bristol-Myers Squibb CO., Church & Dwight Company INC., Cook Medical, INC., and Cooper Surgical Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, partnerships, geographical expansion, and collaborations to stay competitive in the market. For instance, in November 2020, Genea Biomedx (Australia) announced that it has entered into a collaboration agreement with Hamilton Thorne to commercialize Genea Biomedx’s (Australia) fertility products in the US and Canada.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global infertility diagnosis and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Infertility Diagnosis and Treatment Market
- Recovery Scenario of Global Infertility Diagnosis and Treatment Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.1.1.Overview
3.1.2.Financial Analysis
3.1.3.SWOT Analysis
3.1.4.Recent Developments
3.2.Key Strategy Analysis
3.3.Impact of COVID-19 on Key Players
4.Market Segmentation
4.1.Global Infertility Diagnosis and Treatment Market by Diagnosis
4.1.1.Male Infertility Diagnosis
4.1.1.1.Semen Analysis
4.1.1.2.Genetic Testing
4.1.1.3.Testicular Biopsy
4.1.1.4.Hormone Testing
4.1.1.5.Others
4.1.2.Female Infertility Diagnosis
4.1.2.1.Ovulation Testing
4.1.2.2.Hysterosalpingography
4.1.2.3.Hysteroscopy
4.1.2.4.Imaging Testing
4.1.2.5.Ovarian Reserve Testing
4.1.2.6.Hormonal Level Testing
4.1.2.7.Genetic Testing
4.1.2.8.Others
4.2.Global Infertility Diagnosis and Treatment Market by Infertility Treatment
4.2.1.Male Infertility Treatment
4.2.1.1.Drugs and Medicine
4.2.1.2.Surgical
4.2.1.3.Assisted Reproductive Technology (ART)
4.2.1.4.Others
4.2.2.Female Infertility Treatment
4.2.2.1.Drugs and Medicine
4.2.2.2.Surgical
4.2.2.3.Intrauterine Insemination (IUI)
4.2.2.4.Assisted Reproductive Technology (ART)
4.2.2.5.In-Vitro Fertilization (IVF)
4.2.2.6.Intracytoplasmic Sperm Injection (ICSI)
4.2.2.7.Assisted Hatching
4.2.2.8.Others
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Bayer AG
6.2.Bristol-Myers Squibb Co.
6.3.Church & Dwight Co. Inc.
6.4.Cook Medical, Inc.
6.5.Coopersurgical Inc.
6.6.Eli Lilly & Co.
6.7.EMD Serono, Inc
6.8.Endo Pharmaceuticals Inc.
6.9.Ferring Pharmaceuticals
6.10.Genea
6.11.Glaxosmithkline Plc
6.12.Halotech Dna
6.13.Irvine Scientific
6.14.Janssen Pharmaceutical
6.15.Novartis International Ag
6.16.Origio
6.17.Ovascience
6.18.Pfizer Inc.
6.19.Princeton Biomeditech Corp.
6.20.Progyny
6.21.Quidel Corp
6.22.Vitrolife Ab
6.23.Vivus Inc.
1.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
2.GLOBAL MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY INFERTILITY TREATMENT, 2021-2028 ($ MILLION)
5.GLOBAL MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
8.NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
9.NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
10.NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY INFERTILITY TREATMENT, 2021-2028 ($ MILLION)
11.EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12.EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
13.EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY INFERTILITY TREATMENT, 2021-2028 ($ MILLION)
14.ASIA-PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15.ASIA-PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
16.ASIA-PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY INFERTILITY TREATMENT, 2021-2028 ($ MILLION)
17.REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18.REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
19.REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET, 2022-2028 (%)
4.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2021 VS 2028 (%)
5.GLOBAL MALE INFERTILITY DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY INFERTILITY TREATMENT, 2021 VS 2028 (%)
8.GLOBAL MALE INFERTILITY TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL FEMALE INFERTILITY TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.US INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
12.CANADA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
13.UK INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
14.FRANCE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
15.GERMANY INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
16.ITALY INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
17.SPAIN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
18.REST OF EUROPE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
19.INDIA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
20.CHINA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
21.JAPAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
22.SOUTH KOREA INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
23.REST OF ASIA-PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
24.REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2021-2028 ($ MILLION)
